2021
DOI: 10.1111/apt.16647
|View full text |Cite
|
Sign up to set email alerts
|

Use of contraceptives and risk of inflammatory bowel disease: a nested case–control study

Abstract: This is an open access article under the terms of the Creat ive Commo ns Attri bution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(12 citation statements)
references
References 44 publications
1
11
0
Order By: Relevance
“…Pasvol et al 7 have observed an increase in the risk of inflammatory bowel disease in women using combined, instead of progestogen-only, pills in a UK cohort of patients, consistent with Quinn et al 8 that reported that women using oral contraceptives to have higher oxidative stress and CRP.…”
supporting
confidence: 65%
“…Pasvol et al 7 have observed an increase in the risk of inflammatory bowel disease in women using combined, instead of progestogen-only, pills in a UK cohort of patients, consistent with Quinn et al 8 that reported that women using oral contraceptives to have higher oxidative stress and CRP.…”
supporting
confidence: 65%
“…Another possible explanation for our findings is that treatment with certain medications could be an independent risk factor for the development of IBD. Medications such as isotretinoin, antibiotics, nonsteroidal anti-inflammatory drugs, oral contraceptives, mycophenolate mofetil, etanercept, ipilimumab, and rituximab have been linked to causing or worsening IBD (28,39). All of these medications belong to subgroups more used by the IBD population.…”
Section: Discussionmentioning
confidence: 99%
“…21 Oral contraceptives (OCP) use has been shown to increase the risk of IBD by 30% (OR 1.32, 95% CI: 1.17-1.49, p < 0.001, I 2 = 14%), CD by 24% (OR 1.24, 95% CI: 1.09-1.40, p < 0.001, I 2 = 38%) and UC by 30% (OR 1.30, 95% CI: 1.13-1.49, [22][23][24] Longer exposures to OCP were also associated with an increased risk with each additional month of OCP increasing the risk of CD by 6.4% (5.1%-7.7%) and UC by 3.3% (2.1%-4.4%). 23,25 Progesterone-only pills had no risk of developing CD (OR 1.09; 95% CI: 0.84-1.40) but a modest association with UC (OR 1.35; 95% CI: 1.12-1.64). 25 Lastly, parenteral contraceptives were associated with a borderline increased risk of CD (OR 1.15; 95% CI:0.99-1.47) and UC (OR 1.17; 95% CI:0.98-1.39).…”
Section: Exposure To Drugsmentioning
confidence: 99%
“… 22 , 23 , 24 Longer exposures to OCP were also associated with an increased risk with each additional month of OCP increasing the risk of CD by 6.4% (5.1%–7.7%) and UC by 3.3% (2.1%–4.4%). 23 , 25 Progesterone‐only pills had no risk of developing CD (OR 1.09; 95% CI: 0.84–1.40) but a modest association with UC (OR 1.35; 95% CI: 1.12–1.64). 25 Lastly, parenteral contraceptives were associated with a borderline increased risk of CD (OR 1.15; 95% CI:0.99–1.47) and UC (OR 1.17; 95% CI:0.98–1.39).…”
Section: Exposure To Drugsmentioning
confidence: 99%
See 1 more Smart Citation